• 1. Enantiomerically pure 1,3,2-dioxaborolanes: new reagents for the hydroboration of alkynes
  Chem. Commun., 1998, 2651-2652
• 2. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 3. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

Introduction to 4-Amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide (CAS No. 1001500-14-6)

4-Amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide (CAS No. 1001500-14-6) is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research due to its versatile structural framework and potential biological activities. This compound belongs to the pyrazole class, which is well-documented for its broad spectrum of pharmacological properties, including anti-inflammatory, antimicrobial, and anticancer effects. The presence of multiple functional groups, such as an amino group at the 4-position, a methyl group at the 1-position, and a propylamine moiety at the N-position, contributes to its unique chemical properties and reactivity, making it a valuable scaffold for drug discovery and development.

The structural features of 4-amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide make it an attractive candidate for further investigation in synthetic chemistry and pharmacology. The pyrazole ring itself is a core structure in numerous bioactive molecules, and modifications at various positions on this ring can lead to significant changes in biological activity. For instance, the amino group at the 4-position can participate in hydrogen bonding interactions with biological targets, while the propylamine side chain provides a flexible alkyl chain that can influence solubility and metabolic stability.

In recent years, there has been a surge in research focused on developing novel heterocyclic compounds with therapeutic potential. Pyrazole derivatives have been extensively studied due to their ability to modulate various biological pathways. One of the most promising areas of research has been the development of compounds that can inhibit kinases and other enzymes involved in cancer progression. 4-Amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide has shown promise in preclinical studies as a potential kinase inhibitor, particularly due to its ability to interact with the active sites of these enzymes through its functional groups.

Moreover, the compound's structural similarity to known pharmacophores has allowed researchers to leverage existing knowledge about drug design and optimization. By modifying the substituents on the pyrazole ring, scientists can fine-tune the physicochemical properties of 4-amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide, including its solubility, bioavailability, and target specificity. This flexibility makes it an excellent candidate for structure-based drug design approaches.

Recent advancements in computational chemistry have further accelerated the discovery process for novel heterocyclic compounds like 4-amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide. High-throughput virtual screening (HTVS) and molecular docking studies have enabled researchers to rapidly identify potential lead compounds with high binding affinity to biological targets. These computational methods have been particularly useful in predicting the binding modes of 4-amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide to various enzymes and receptors, providing insights into its mechanism of action.

The synthesis of 4-amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. The synthesis typically begins with the formation of the pyrazole core through condensation reactions between appropriate precursors. Subsequent functionalization steps introduce the amino group at the 4-position and the propylamine side chain at the N-position. These steps often involve nucleophilic substitution reactions or reductive amination techniques.

The chemical stability of 4-amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide is another critical factor that must be considered during synthesis and storage. The compound's susceptibility to degradation under various conditions can affect its efficacy in biological assays. Researchers have explored strategies such as protecting group strategies and controlled reaction environments to enhance stability during synthetic processes.

In terms of applications, 4-amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide has shown potential in several areas of pharmaceutical research. One notable area is its use as an intermediate in the synthesis of more complex drug molecules. By serving as a building block, this compound can be incorporated into larger scaffolds that exhibit enhanced biological activity or improved pharmacokinetic properties.

Additionally, 4-amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide has been investigated for its potential role in treating inflammatory diseases. Inflammatory responses are mediated by complex signaling pathways involving various enzymes and cytokines. Pyrazole derivatives have been shown to modulate these pathways by inhibiting key enzymes such as cyclooxygenases (COX) or lipoxygenases (LOX). The presence of multiple functional groups in 4-amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide may enable it to interact with multiple targets within these pathways, potentially leading to more effective anti-inflammatory effects.

The compound's ability to cross cell membranes also makes it an attractive candidate for topical applications. By optimizing its lipophilicity through structural modifications, researchers can enhance its penetration into skin tissues, allowing for localized treatment of inflammatory conditions without systemic side effects.

Future research directions for 4-amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide include exploring its interactions with additional biological targets beyond kinases and inflammatory enzymes. By expanding the scope of screening assays and employing advanced biophysical techniques such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, scientists can gain deeper insights into its mechanism of action.

Furthermore, green chemistry principles are being increasingly applied to improve the sustainability of synthetic processes for compounds like 4-amino-1-methyl-N-propyl-1H-pyrazole-5-carboxamide. This includes using environmentally friendly solvents, reducing waste generation through catalytic methods, and optimizing reaction conditions for energy efficiency.

In conclusion, 4-amino - 1 -methyl - N - propyl - 1 H - pyrazole - 5 - carboxamide (CAS No . 1001500 -14 -6) represents a promising scaffold for pharmaceutical development with diverse applications ranging from cancer therapy to anti-inflammatory treatments . Its unique structural features , coupled with recent advances in computational chemistry and synthetic methodologies , make it an exciting compound for further exploration . As research continues , we can expect new insights into its potential therapeutic applications , paving the way for novel treatments that address unmet medical needs . p >

• 1820687-38-4(4-Amino-2-methyl-N-(2-methylpropyl)pyrazole-3-carboxamide;hydrochloride)
• 1001500-37-3(4-amino-1-methyl-N-(2-methylpropyl)-1H-pyrazole-5-carboxamide)
• 1001500-40-8(4-amino-1-methyl-N-(1-methyl-1H-pyrazol-4-yl)methyl-1H-pyrazole-5-carboxamide)
• 906087-59-0(1H-Pyrazole-5-carboxamide, 4-amino-N-cyclopentyl-1-methyl-)
• 1431964-37-2(4-Amino-N-ethyl-2-methylpyrazole-3-carboxamide;hydrochloride)
• 1431965-83-1(4-Amino-N-butyl-2-methylpyrazole-3-carboxamide;hydrochloride)
• 1001500-82-8(1-methyl-5-(piperidine-1-carbonyl)-1H-pyrazol-4-amine)
• 1006483-54-0(4-amino-N-ethyl-1-methyl-1H-pyrazole-5-carboxamide)
• 1006453-68-4(4-amino-1-ethyl-N-(2-methylpropyl)-1H-pyrazole-5-carboxamide)
• 957261-73-3(4-Amino-N,1-dimethyl-1H-pyrazole-5-carboxamide)